Virbac SA announced revenue results for the first quarter of 2024. First-quarter revenue amounted to ?345.7 million, up +9.8% at actual exchange rates compared to the same period in 2023. Excluding acquisitions and at constant exchange rates, revenue growth was +9.7%.

Buoyed by stronger momentum in the animal health market, this remarkable progression was driven firstly by an estimated 6.4 points growth contribution from volumes, and to a lesser extent, by a more modest price effect, due in particular to the slowdown in inflation.